JME Group, Inc. is a privately held, biotechnology company founded on March 2014 in New Jersey, U.S.
The company embarked on a project to develop and commercialize a safer and affordable enzyme replacement therapy (ERT) for metabolic and lysosomal storage diseases (a group of rare (orphan) diseases deficient in lysosomal enzymes) via oral administration (hence Oral-ERT) using plant-derived recombinant human enzymes or proteins plus natural non-GMO plant products for improvement of human and animal health. The first enzyme in the pipeline using this platform is a recombinant human lysosomal acid alpha-glucosidase (GAA) or acid maltase produced in tobacco seeds for the treatment of acid maltase deficiency (AMD or POMPE disease).
Company Details
- Employees
- 3
- Founded
- 2014
- Address
- 215 College Rd, Paramus,new Jersey 07652,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.jmescience.com/
- Keywords
- Seva Therapeutics Inc..
- HQ
- Paramus, New Jersey
Jme Group Inc Questions
Jme Group Inc's website is http://www.jmescience.com/
Jme Group Inc's LinkedIn profile is https://www.linkedin.com/company/jme-science
Jme Group Inc has
3 employees.
View email and phone details for 3
employees at Jme Group Inc.
Jme Group Inc's industry is
Biotechnology Research
Jme Group Inc's categories are Biotechnology Research
Jme Group Inc's founding year is 2014
